case_images: PMC7682475_01
case_images: Effect of tocilizumab on inflammatory markers. IL-6, interleukin-6; CRP, C-reactive protein.
case_images: CRIN2020-8829309.001.jpg
case_images: PMC7682475_01_CRIN2020-8829309.001.jpg
case_images: fig1
case_images: His inflammatory markers such as C-reactive protein (CRP), IL-6, and ferritin were significantly elevated (Figure 1).
case_images: Chest X-ray AP view showing extensive bilateral perihilar and basal opacities on day 2 (a), which has improved significantly by day 4 as shown in (b).
case_images: CRIN2020-8829309.002.jpg
case_images: PMC7682475_01_CRIN2020-8829309.002.jpg
case_images: fig2
case_images: On day 4, significant improvement occurred as shown by decreased breathlessness, decreased support of NIV and O2 requirements, and improvement in the bilateral chest infiltrates as demonstrated by chest X-ray (Figure 2).